| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.009 |